AAP
KNSA icon

Arax Advisory Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Arax Advisory Partners’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
3,451
+3,431
+17,155% +$178K ﹤0.01% 2187
2026
Q1 		$963 Buy
20
+17
+567% +$753 ﹤0.01% 3307
2025
Q4 		$124 Sell
3
-4,006
-100% -$161K ﹤0.01% 3794
2025
Q3 		$156K Buy
+4,009
New +$130K ﹤0.01% 1357
2025
Q1 		– Sell
-1
Closed -$20 – 2882
2024
Q4 		$20 Hold
1
– – ﹤0.01% 2407
2024
Q3 		$25 Hold
1
– – ﹤0.01% 2600
2024
Q2 		$19 Buy
+1
New +$19 ﹤0.01% 2527

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Arax Advisory Partners's KNSA Position: Q2 2026 in Review

Arax Advisory Partners increased its Kiniksa Pharmaceuticals (KNSA) stake by 17,155% in Q2 2026, buying an estimated $178K and bringing the position to 3,451 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #2187.

Arax Advisory Partners first reported a position in KNSA in Q2 2024 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Arax Advisory Partners held 3,451 shares of Kiniksa Pharmaceuticals worth $221K as of Q2 2026.
  • Arax Advisory Partners bought 3,431 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $178K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2187 holding.
  • Arax Advisory Partners first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.